A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.
- DOI
- 10.3390/ijms232214060
- Published
- 2022 Nov 14
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms232214060,
title = {A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.},
author = {Chen W and Zhu L and Wang L and Zeng J and Wen M and Xu X and Zou L and Huang F and Huang Q and Qin D and Mei Q and Yang J and Wang Q and Wu J},
year = {2022},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms232214060},
url = {https://doi.org/10.3390/ijms232214060}
}RIS
TY - JOUR TI - A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways. AU - Chen W AU - Zhu L AU - Wang L AU - Zeng J AU - Wen M AU - Xu X AU - Zou L AU - Huang F AU - Huang Q AU - Qin D AU - Mei Q AU - Yang J AU - Wang Q AU - Wu J PY - 2022 JO - International journal of molecular sciences DO - 10.3390/ijms232214060 UR - https://doi.org/10.3390/ijms232214060 ER -
APA
W, C., L, Z., L, W., J, Z., M, W., X, X., L, Z., F, H., Q, H., D, Q., Q, M., J, Y., Q, W., & J, W. (2022). A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.. International journal of molecular sciences. https://doi.org/10.3390/ijms232214060
Source records
- pubmed · retrieved 2026-09-24T21:25:16.235Z